Kidney fibrosis: from mechanisms to therapeutic medicines
Rongshuang Huang, Ping Fu, Liang Ma · Signal Transduction and Targeted Therapy · 2023 · Review
Full textCC BY
Medicine: papers
Filters2 filters applied
Year
Readable here
Study type
8 papersQuestions on this topic
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
Carmine Zoccali, Francesca Mallamaci, Marcin Adamczak et al. · Cardiovascular Research · 2023 · Review
Full textCC BY
Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies
Wenshan Lv, George W. Booz, Fan Fan et al. · Frontiers in Physiology · 2018 · Review
Full textCC BY
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
José M López-Novoa, Ana B Rodríguez-Peña, Alberto Ortiz et al. · Journal of Translational Medicine · 2011 · Review
Full textCC BY
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study
Daniel M. Jordan, Hyon K. Choi, Marie Verbanck et al. · PLOS Medicine · 2019
Full textCC BY
Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways
Hongtao Tan, Junxian Chen, Yicong Li et al. · Molecular Medicine · 2022
Full textCC BY
Risk Models to Predict Chronic Kidney Disease and Its Progression: A Systematic Review
Justin B. Echouffo-Tcheugui, Andre P. Kengne · PLoS Medicine · 2012 · Systematic review
Full textCC BY
Machine learning for the prediction of acute kidney injury in patients with sepsis
Suru Yue, Shasha Li, Xueying Huang et al. · Journal of Translational Medicine · 2022
Full textCC BY